Singapore’s Latest Vaccine Brand: Everything You Need to Know

If you’re living in Singapore, you’re probably aware of the country’s vaccination efforts against COVID-19. Singapore has been actively vaccinating its citizens since December 2020, and the government has been working hard to ensure that everyone who wants to get vaccinated can do so. In this article, we’ll take a closer look at the vaccine brands used in Singapore, their efficacy and safety, and other important information related to Singapore’s vaccination strategy.

A vial of Singapore vaccine brand sits on a clean, white surface, surrounded by medical equipment and a symbol of the nation's healthcare system

Singapore’s vaccination strategy is based on the principles of protecting public health and ensuring the safety of its citizens. The government has made it a top priority to vaccinate as many people as possible, starting with high-risk groups such as healthcare workers and the elderly. Vaccinations are free for all Singaporeans and long-term residents, and the government has set up various vaccination centres across the country to make it easier for people to get vaccinated.

When it comes to the vaccine brands used in Singapore, there are currently three options available: Pfizer-BioNTech/Comirnaty, Moderna/Spikevax, and Sinovac-CoronaVac. Pfizer-BioNTech and Moderna have both been fully registered in Singapore, while Sinovac-CoronaVac is still included under the National Vaccination Programme until 30 September 2024. In the next section, we’ll take a closer look at the efficacy and safety of these vaccines and what you need to know before getting vaccinated.

Key Takeaways

  • Singapore’s vaccination strategy is focused on protecting public health and ensuring the safety of its citizens.
  • The three vaccine brands currently used in Singapore are Pfizer-BioNTech/Comirnaty, Moderna/Spikevax, and Sinovac-CoronaVac.
  • Vaccinations are free for all Singaporeans and long-term residents, and the government has set up various vaccination centres across the country to make it easier for people to get vaccinated.

Overview of Singapore’s Vaccination Strategy

A bustling vaccination center with people waiting in line, healthcare workers administering vaccines, and informational posters about the Singapore vaccine brand displayed prominently

If you are living in Singapore, you may be wondering about the country’s COVID-19 vaccination strategy. In this section, we will provide you with an overview of the national vaccination programme, vaccine supplies, and partnerships.

National Vaccination Programme

Singapore’s Ministry of Health (MOH) has launched a national vaccination programme to protect the population against COVID-19. The programme is being rolled out in phases, with priority given to healthcare workers, frontline personnel, and vulnerable groups such as the elderly and those with underlying medical conditions.

According to the MOH, the vaccination programme is free for all Singaporeans and long-term residents. The government aims to vaccinate the entire adult population by the end of 2021.

Vaccine Supplies and Partnership

To ensure adequate vaccine supplies, the Singapore government has secured multiple vaccine candidates from different manufacturers. The vaccines that have been approved for use in Singapore are Pfizer-BioNTech, Moderna, and Sinovac.

The Health Sciences Authority (HSA) is responsible for evaluating and approving all COVID-19 vaccines before they can be used in Singapore. The HSA has stated that all approved vaccines have been rigorously tested for safety and efficacy.

In addition to securing vaccine supplies, the Singapore government has also partnered with vaccine manufacturers to develop and manufacture vaccines locally. For example, the government has partnered with Novavax to produce its COVID-19 vaccine, Nuvaxovid, in Singapore.

Overall, Singapore’s vaccination strategy is aimed at protecting the population against COVID-19 while ensuring that the vaccines used are safe and effective. The government’s efforts to secure vaccine supplies and partnerships show its commitment to this goal.

Vaccine Brands Used in Singapore

Various vaccine brand logos displayed on a clinic wall in Singapore

If you’re living in Singapore, you have access to a range of COVID-19 vaccines. Here are the vaccine brands used in Singapore:

Pfizer-BioNTech/Comirnaty

Pfizer-BioNTech/Comirnaty is one of the vaccines authorised by the Health Sciences Authority (HSA) for use in Singapore. It is a two-dose mRNA vaccine that has been shown to be highly effective against COVID-19. The vaccine has been approved for use in individuals aged 12 years and above.

Moderna/Spikevax

Moderna/Spikevax is another mRNA vaccine that has been approved by the HSA for use in Singapore. Like Pfizer-BioNTech/Comirnaty, it is a two-dose vaccine that has been shown to be highly effective against COVID-19. The vaccine has been approved for use in individuals aged 18 years and above.

Sinovac-Coronavac

Sinovac-Coronavac is a vaccine that continues to be included under the National Vaccination Programme in Singapore. It is an inactivated virus vaccine that has been approved for use in individuals aged 18 years and above. While this vaccine has been shown to be effective against COVID-19, its efficacy rate is lower than that of the mRNA vaccines.

Novavax/Nuvaxovid

Novavax/Nuvaxovid is a protein subunit vaccine that has not yet been approved for use in Singapore. However, it is currently undergoing clinical trials in the country.

When it comes to the safety profiles of these vaccines, they have all been shown to be generally safe and well-tolerated. Like all vaccines, they may cause side effects, but these are usually mild and short-lived.

In terms of efficacy, the mRNA vaccines (Pfizer-BioNTech/Comirnaty and Moderna/Spikevax) have been shown to be highly effective at preventing COVID-19. Sinov